NCT03471884|Unknown
Loading search results
Sponsor study identifier
interventional
82
1 country
1
Study Start
March 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
December 31, 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 31, 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
A novel nonintubated thoracoscopic technique is promising to enhance recovery after thoracic surgery. However, the effects of nonintubated technique on specific organ protection in not clear yet. In this randomized trial, the effect of nonintubated technique on lung function protection will be evaluated via PaO2/FiO2 ratio, oxidative stress and inflammatory cytokines serially in lung cancer patients undergoing thoracoscopic lobectomy.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
March 13, 2018
Actual (reported)March 21, 2018
Actual (reported)December 31, 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 31, 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Lung function assessment
Lung function will be assessed by serial arterial blood gas analyses to obtain oxygenation index (PaO2/FiO2).
12 hours
Oxidative and systemic inflammatory cytokines.
24 hours
Lung cancer patients undergoing thoracoscopic lobectomy without tracheal intubation
Lung cancer patients undergoing thoracoscopic lobectomy with tracheal intubation and one-lung ventilation
Nonintubated general anesthesia using fentanyl, target-controlled infusion of propofol to achieve a bispectral index value between 40 and 60. One-lung ventilation will be achieved via a spontaneous breathing due to iatrogenic pneumothorax.
Intubated general anesthesia using 2%-3% sevoflurane and rocuronium to achieve a bispectral index value between 40 and 60. One-lung ventilation will be achieved via a endobronchial tube or blocker with use of mechanical ventilation.
National Taiwan University Hospital
Taipei, 100, Taiwan
Ming-Hui Hung, MD, MSc
National Taiwan University Hospital
First Submitted
March 13, 2018
First Posted
March 21, 2018
Study Start
March 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
December 31, 2018
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 31, 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
March 21, 2018
Record last verified: 2018-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: